Showing results (211-220 of 226) with videos related to

Sort By:
Pageof 23
International Journal of Epidemiology|May 14, 2016
Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in ChinaWenzhou Yu, Dawei Liu, Jingshan Zheng, et al.
Nature Medicine|December 9, 2014
Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesisJustin D Crane, Rengasamy Palanivel, Emilio P Mottillo, et al.
Journal of Gastrointestinal Oncology|September 12, 2022
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)Xiang Wang, Diansheng Zhong, Junping Zhang, et al.
Eclinicalmedicine|September 2, 2025
Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 studyJunning Cao, Guangliang Chen, Lihua Qiu, et al.
BMC Cancer|January 24, 2024
Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 studyYan Qin, Yongping Song, Dong Wang, et al.
Blood Advances|July 26, 2024
CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphomaPier Luigi Zinzani, Huaqing Wang, Jifeng Feng, et al.
China CDC Weekly|October 1, 2021
Detection and Initial Response to a Type 2 Vaccine-Derived Poliovirus - Sichuan Province, China, 2019Jiushun Zhou, Ning Wen, Yong Zhang, et al.
JAMA Network Open|January 5, 2023
Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021Hong Yang, Qi Qi, Yong Zhang, et al.
Therapeutic Advances in Medical Oncology|March 29, 2020
An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)Xiang Wang, Ruixing Zhang, Nan Du, et al.
American Journal of Cancer Research|April 9, 2020
Safety and effectiveness of apatinib in patients with previously treated metastatic gastric cancer: a sub-analysis from the real-world study of apatinib for gastric cancer treatment (AHEAD-G202)Xiang Wang, Junyan Yu, Mudan Yang, et al.
Pageof 23